Free Trial
NASDAQ:VCNX

Vaccinex (VCNX) Stock Price, News & Analysis

Vaccinex logo
$0.71 -0.04 (-5.33%)
As of 08/7/2025 10:07 AM Eastern

About Vaccinex Stock (NASDAQ:VCNX)

Key Stats

Today's Range
$0.58
$0.71
50-Day Range
$0.66
$1.05
52-Week Range
$0.25
$1.40
Volume
3,105 shs
Average Volume
2,993 shs
Market Capitalization
$1.85 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive VCNX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Vaccinex and its competitors with MarketBeat's FREE daily newsletter.

VCNX Stock News Headlines

Protect Your Bank Account with THESE 4 Simple Steps
Starting as soon as a few months from now, the United States government will make a sweeping change to bank accounts nationwide. It will give them unprecedented powers to control your bank account.
See More Headlines

VCNX Stock Analysis - Frequently Asked Questions

Vaccinex's stock was trading at $0.98 on January 1st, 2025. Since then, VCNX shares have decreased by 27.6% and is now trading at $0.71.

Vaccinex, Inc. (NASDAQ:VCNX) released its quarterly earnings results on Monday, November, 8th. The company reported ($35.70) earnings per share (EPS) for the quarter, beating the consensus estimate of ($60.90) by $25.20. The business earned $0.05 million during the quarter.

Vaccinex shares reverse split before market open on Tuesday, February 20th 2024.The 1-14 reverse split was announced on Tuesday, February 20th 2024. The number of shares owned by shareholders was adjusted after the closing bell on Tuesday, February 20th 2024. An investor that had 100 shares of stock prior to the reverse split would have 7 shares after the split.

Vaccinex (VCNX) raised $45 million in an initial public offering on Thursday, August 9th 2018. The company issued 3,300,000 shares at $12.00-$15.00 per share. Oppenheimer and BTIG acted as the underwriters for the IPO and Ladenburg Thalmann was co-manager.

Shares of VCNX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Vaccinex investors own include Pfizer (PFE), VBI Vaccines (VBIV), OPKO Health (OPK), Plug Power (PLUG), Vaxart (VXRT), NIO (NIO) and SNDL (SNDL).

Company Calendar

Last Earnings
11/08/2021
Today
8/07/2025
Next Earnings (Estimated)
8/12/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:VCNX
CIK
1205922
Employees
40
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($48.27)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$20.25 million
Net Margins
N/A
Pretax Margin
-4,787.89%
Return on Equity
N/A
Return on Assets
-383.58%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.77
Quick Ratio
0.77

Sales & Book Value

Annual Sales
$388 thousand
Price / Sales
4.76
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($2.59) per share
Price / Book
-0.27

Miscellaneous

Outstanding Shares
2,600,000
Free Float
1,261,000
Market Cap
$1.85 million
Optionable
No Data
Beta
1.10

Social Links

7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report

This page (NASDAQ:VCNX) was last updated on 8/8/2025 by MarketBeat.com Staff
From Our Partners